←Back to feed
📰 Mixed⚪ Neutral
‘Usually everybody loves money’: Trump’s FDA chief to start giving bonuses for faster drug reviews
🤖AI Summary
Trump's FDA chief plans to implement bonuses to accelerate drug approval processes, aiming to reduce approval times from up to 29 months to as low as 6 months. This comes after the FDA lost approximately 20% of its workforce following Trump's presidency.
Key Takeaways
- →The FDA experienced a 20% workforce reduction after Trump took office last year.
- →New bonus incentive system aims to motivate faster drug review processes.
- →Target is to reduce drug approval timeframes from 29 months to potentially 6 months.
- →The initiative represents a significant shift in FDA operational approach under Trump's administration.
- →Faster approvals could accelerate pharmaceutical industry development cycles.
Read Original →via Fortune Crypto
Act on this with AI
Stay ahead of the market.
Connect your wallet to an AI agent. It reads balances, proposes swaps and bridges across 15 chains — you keep full control of your keys.
Related Articles
